-
DiscoveryProbe™ FDA-approved Drug Library: Accelerating C...
2026-01-21
Discover how the DiscoveryProbe FDA-approved Drug Library empowers advanced drug repositioning and chemosensitization research. Explore unique insights into pharmacological target identification and high-content screening, grounded in recent scientific breakthroughs.
-
PF-562271 HCl: ATP-Competitive FAK/Pyk2 Inhibitor for Can...
2026-01-20
PF-562271 HCl is a nanomolar-potency, reversible FAK/Pyk2 inhibitor that disrupts focal adhesion kinase signaling for cancer research. Its high selectivity and robust inhibition of tumor growth and metastasis position it as a critical tool for mechanistic studies and drug discovery.